161 related articles for article (PubMed ID: 20456710)
1. Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling.
Bourgeaux V; Hequet O; Campion Y; Delcambre G; Chevrier AM; Rigal D; Godfrin Y
Transfusion; 2010 Oct; 50(10):2176-84. PubMed ID: 20456710
[TBL] [Abstract][Full Text] [Related]
2. Effect of inositol hexaphosphate-loaded red blood cells (RBCs) on the rheology of sickle RBCs.
Lamarre Y; Bourgeaux V; Pichon A; Hardeman MR; Campion Y; Hardeman-Zijp M; Martin C; Richalet JP; Bernaudin F; Driss F; Godfrin Y; Connes P
Transfusion; 2013 Mar; 53(3):627-36. PubMed ID: 22804873
[TBL] [Abstract][Full Text] [Related]
3. Sickling as a function of oxygen delivery: effect of simulated transfusions of stored, fresh and inositol-hexaphosphate-loaded (low affinity) red cells.
Kumpati J; Franco RS; Weiner M; Martelo OJ
Blood Cells; 1982; 8(2):263-72. PubMed ID: 7159750
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of homologous inositol hexaphosphate-loaded red blood cells in sickle transgenic mice.
Bourgeaux V; Aufradet E; Campion Y; De Souza G; Horand F; Bessaad A; Chevrier AM; Canet-Soulas E; Godfrin Y; Martin C
Br J Haematol; 2012 May; 157(3):357-69. PubMed ID: 22404654
[TBL] [Abstract][Full Text] [Related]
5. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sickling after reduction of intracellular hemoglobin concentration with an osmotic pulse: characterization of the density and hemoglobin concentration distributions.
Franco RS; Barker-Gear R; Green R
Blood Cells; 1993; 19(2):475-88; discussion 489-91. PubMed ID: 8312575
[TBL] [Abstract][Full Text] [Related]
7. Modification of the oxygen affinity and intracellular hemoglobin concentration of normal and sickle cells by means of an osmotic pulse.
Franco RS; Barker RL
J Lab Clin Med; 1989 Jan; 113(1):58-66. PubMed ID: 2909651
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
[TBL] [Abstract][Full Text] [Related]
9. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.
Head CA; Brugnara C; Martinez-Ruiz R; Kacmarek RM; Bridges KR; Kuter D; Bloch KD; Zapol WM
J Clin Invest; 1997 Sep; 100(5):1193-8. PubMed ID: 9276736
[TBL] [Abstract][Full Text] [Related]
10. A rat model for sickle cell-mediated vaso-occlusion in retina.
Lutty GA; Phelan A; McLeod DS; Fabry ME; Nagel RL
Microvasc Res; 1996 Nov; 52(3):270-80. PubMed ID: 8954868
[TBL] [Abstract][Full Text] [Related]
11. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
Ueda Y; Bookchin RM
J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-dependent circulation of sickle erythrocytes.
Castro O; Osbaldiston GW; Aponte L; Roth R; Orlin J; Finch SC
J Lab Clin Med; 1976 Nov; 88(5):732-44. PubMed ID: 988104
[TBL] [Abstract][Full Text] [Related]
13. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(2):83-97. PubMed ID: 15004333
[TBL] [Abstract][Full Text] [Related]
14. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
[TBL] [Abstract][Full Text] [Related]
15. Vaso-occlusive crisis episodes in sickle cell disease.
Adhikary PK; Hara S; Dwivedi C; Davis JW; Weaver C; Pavuluri SR
J Med; 1986; 17(3-4):227-40. PubMed ID: 3473166
[TBL] [Abstract][Full Text] [Related]
16. Quaternary structure of carbonmonoxyhemoglobins in solution: structural changes induced by the allosteric effector inositol hexaphosphate.
Gong Q; Simplaceanu V; Lukin JA; Giovannelli JL; Ho NT; Ho C
Biochemistry; 2006 Apr; 45(16):5140-8. PubMed ID: 16618103
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea in the treatment of sickle-cell anemia.
Howard LW; Kennedy LD
Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
[TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
[TBL] [Abstract][Full Text] [Related]
19. Red cell exchange: special focus on sickle cell disease.
Kim HC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):450-6. PubMed ID: 25696893
[TBL] [Abstract][Full Text] [Related]
20. Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease.
Barabino GA; McIntire LV; Eskin SG; Sears DA; Udden M
Prog Clin Biol Res; 1987; 240():113-27. PubMed ID: 3615482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
